Glomerular filtration rate in patients with Cushing's disease: A matched case-control study

European Journal of Endocrinology

Volumn 153, Issue 6, 2005, Pages 819-829

  Haentjens, P ^c   De Meirleir, L ^c   Abs, R ^a   Verhelst, J ^b   Poppe, K ^c   Velkeniers, B ^c  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b MIDDELHEIM HOSPITAL   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DEXAMETHASONE;

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE CLEARANCE; CUSHING DISEASE; DISEASE DURATION; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION TEST; MALE; MICROALBUMINURIA; MULTIPLE REGRESSION; OUTCOMES RESEARCH; PATIENT MONITORING; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADENOMA; AGED; ALBUMINURIA; CASE-CONTROL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS; REGRESSION ANALYSIS;

EID: 29644443627     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02040     Document Type: Article

References (35)

1. Greenblatt SH. Harvey Cushing's paradigmatic contribution to neurosurgery and the evolution of his thought on his specialisation. Bulletin of the History of Medicine 2003 77 789-822.
2. Trainer PJ & Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome. Clinical Endocrinology (Oxford) 1991 34 317-330.
3. Newell-Price J, Trainer P, Besser M & Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and Pseudo-Cushing's states. Endocrine Reviews 1998 19 647-672.
4. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferrone D, Filippella M, Marzullo P, Cerbone G, Sicilliani M & Lombardi G. Persistance of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.Journal of Clinical Endocrinology and Metabolism 1999 84 2664-2672.
5. Leoncini G, Viazzi F, Parodi D, Vettoretti S & Ratto E. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension 2003 42 14-18.
6. Chen J, Muntner P, Hamm L, Jones DW, Batuman V, Fonseca V, Whelton PK & Jiang H. The metabolic syndrome and chronic kidney disease in U.S. adults. Annals of Internal Medicine 2004 140 167-174.
7. Hatton J, Parr M & Blouin RA. Estimation of creatinine clearance in patients with Cushing's syndrome. DICP 1989 23 974-977.
8. Koh J-M, Kim JY, Park JY, Shong YK, Hong SK, Kim GS & Lee KU. Increased urinary albumin excretion in Cushing's syndrome: remission after correction of hypercotisolemia. Clinical Endocrinology 2000 52 349-353.
9. Faggiano A, Pivonello R, Melis D, Alfieri R, Filippella M, Spagnulo G, Salvatore F, Lombardi G & Colao A. Evaluation of circulating levels and renal clearance of natural amino acids in patients with Cushing's disease. Journal of Endocrinological Investigation 2002 25 142-151.
10. Faggiano A, Pivonello R, Filippella M, Di Somma C, Petretta M, Lombardi G & Colao A. Nefrolithiasis in Cushing's disease: prevalence, ethiopathogenesis and modification after disease cure. Journal of Clinical Endocrinology and Metabolism 2003 88 2076-2080.
11. Arnaldi G & Angeli A. Diagnosis and complications of Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2003 88 5593-5602.
12. Anon. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: the Evidence Report, pp 98-4083, NIH publication. Bethesda, MD: National Institutes of Health, 1998.
13. Anon, World Health Organisation-International Society of Hypertension guidelines for the management of hypertension. Guidelines Subcommittee. Journal of Hypertension 1999 17 151-183.
14. Larn TK & Leung DR. More on simplified calculation of body surface area. New England Journal of Medicine 318 1130.
15. Cockcroft DW & Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 31-41.
16. Levey AS & Bosch JP. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine 1999 130 461-470.
17. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Erlbaum, 1988.
18. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes M, Hogg R, Perrone R, Lau J & Eknoyan G. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Annals of Internal Medicine 2003 139 137-147.
19. Urbanic RC & George JM. Cushing's disease: 18 years of experience. Medicine 1981 60 14-26.
20. Ross EJ & Linch DC. Cushing's syndrome - killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 1982 2 646-649.
21. Pirpiris M. Sudhir K & Yeung S. Pressor responsiveness in corticosteroid induced hypertension in humans. Hypertension 1992 19 571-574.
22. Brem AS. Insights into glucocorticoid associated hypertension. American Journal of Kidney Diseases 2001 37 1-10.
23. Brem AS, Bina RB, Mehta S & Marshall J. Glucocorticoids inhibit the expression of calcium-dependent potassium channels in vascular smooth muscle. Molecular Genetics and Metabolism 1999 67 573-577.
24. Whitworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GJ & Kelly JJ. The nitric oxide system in glucocorticoid-induced hypertension. Journal of Hypertension 2002 20 1035-1043.
25. Wallerath I, Witte K, Schafer SC, Schwartz PM, Prellwitz W, Kleinert H, Lehr HA, Lemmer B & Fortstermann U. Down-regulation of the expression of endothelial NO synthetase is likely to contribute to glucocorticoid-mediated hypertension. PNAS 1999 96 1357-1362.
26. Kelly JJ, Williamson P, Martin A & Whitworth JA. Effects of oral L-arginine on plasma nitrate and blood pressure in cortisol-treated humans. Journal of Hypertension 2001 19 263-268.
27. Mangos GJ, Walker BR, Kelly JJ, Lawson JA, Webb DJ & Whitworth JA. Cortisol inhibits cholinergic vasodilatation in the human forearm. American Journal of Hypertension 2000 13 1155-1160.
28. Iuchi T, Akaike M, Mitsui T & Ohshima Y. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circulation Research 2003 92 81-87.
29. Sala C, Ambriosi B & Morganti A. Blunted vascular and renal effects of exogenous atrial natriuretic peptide in patients with Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2001 86 1957-1961.
30. Connell JM, Whitworth JA, Davies DL, Lever AF, Richards AM & Fraser R. Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. Journal of Hypertension 1987 5 425-433.
31. Verhave JC, Gansevoort RT, Hillege HL, de Zeeuw D, Curhan GC & de Jong PE. (for the PREVEND Study Group). Drawbacks of the use of indirect estimations of renal function to evaluate the effect of risk factors on renal function. Journal of the American Society of Nephrology 2004 15 1316-1322.
32. Hayashi Y, Morikawa A & Makino M. Heterogenicity of urinary albumin from diabetic patients. Clinica Chimica Acta 1990 190 93-103.
33. Babazono T Kapor-Drezgic J & Whiteside C. Altered expression and subcellular localisation of diacylglycerol-sensitive protein kinase isoforms in diabetic rat glomerular cells. Diabetes 1998 47 668-676.
34. Coresh J, Astor B, McQuillan G, Kusek J, Greene T, Van Lente & Levey A. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. American Journal of Kidney Diseases 2002 39 920-929.
35. Stevens L & Levey A. Measurement of kidney function. Medical Clinics of North America 2005 89 457-473.